Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2025 | The AI-enhanced neurologist: what does the future hold?

Daniel Goldenholz, MD, PhD, FAES, Harvard Medical School, Boston, MA, comments on the practical developments in artificial intelligence (AI) for neurologists. He highlights the availability of FDA-approved AI-enhanced tools in imaging and the potential for future advancements to improve workflows and patient care. This interview took place at the 77th American Academy of Neurology (AAN) Annual Meeting in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

At the AAN, we had a little group talking about some practical developments in AI, and my talk was really about what does it look like to be an AI-enhanced neurologist. And so we discussed a variety of things, including some of the FDA-approved AI-enhanced tools that are already available in imaging, EEG, and so on. And then we talked about some broader tools that are not FDA cleared, but are being used and are usable for neurologists at present...

At the AAN, we had a little group talking about some practical developments in AI, and my talk was really about what does it look like to be an AI-enhanced neurologist. And so we discussed a variety of things, including some of the FDA-approved AI-enhanced tools that are already available in imaging, EEG, and so on. And then we talked about some broader tools that are not FDA cleared, but are being used and are usable for neurologists at present. And so I talked about some websites and gave a few quick examples. And then I also talked about some apps that connect to those things. And then we moved on to what are the differences between the way things used to be done, the way things currently are done now that they can be somewhat AI enhanced, and what are ways that very soon they will be more AI enhanced. And so the difference between a more future-forward type talk like, oh, someday we’ll all be on flying cars and dancing over rainbows, is that there are tools that are available now and we can use them now. And they can now currently speed up our workflows, as well as enhance our abilities to get things done in an effective way as opposed to just faster, it’s also better. But there’s also the promise that these tools continue to improve at a very rapid rate so that as we continue to learn these tools and new tools become available, we can do a better job for our patients and also do things in better and faster, more efficient ways of getting things accomplished. So it was kind of a whirlwind overview in only a few minutes of those concepts.

 

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Disclosures

DMG is an unpaid advisor for Epilepsy AI and Eysz. He has been a paid advisor for Magic Leap. He has been provided speaker fees from AAN, AES, ACNS, NNS and AI in Epilepsy and Neurology and Florida Neuroscience Network Epilepsy Alliance. He also previously has been a paid consultant for Neuro Event Labs, IDR, LivaNova, Health Advances, Duke University, and Bloom Insights. He has received grants from NIH and BIDMC.